This paper examines heart valve disease and its impact on cardiac function in patients experiencing heart failure. It identifies major valve deformities including mitral valve prolapse, mitral stenosis, mitral regurgitation, aortic stenosis, and aortic regurgitation, explaining how each condition disrupts normal blood flow. The paper discusses the physiological mechanisms by which valve damage forces the heart to work harder, leading to fluid accumulation, acute decompensation, and potential cardiac arrest. It concludes by reviewing clinical treatment approaches including supplemental oxygen, ventilators, and pharmaceutical interventions designed to reduce cardiac strain and manage symptoms.
Heart disease affects approximately 735,000 Americans annually. Most patients develop heart failure due to inactivity and poor diet, which makes it difficult for the body to pump blood adequately to the rest of the body. Older adults often develop this condition due to weight gain and accumulate excessive fluid in their legs and arms. Patients suffering from heart failure typically present with blood pressures of 160/100 mmHg and above, with arterial pressures reaching 179/109 mmHg and central venous pressures at 180/110 mmHg. This extreme pressure places tremendous strain on the heart's valves. Once damage occurs, it can become severe and negatively impact the patient's underlying health, potentially causing cardiac arrest (Silverstein, 2006). Understanding the extent of valve injuries, associated deformities, and their impact on cardiac function reveals the long-term effects of this condition on heart health.
Heart valve disease is a problem with one or more of the heart's valves. These structures are openings that move in a forward direction and allow blood to flow easily through different cardiac chambers. Each valve pumps and filters blood around the body using a complex network of vessels and arteries. The valves open and close to allow the flow of oxygen and nutrients to various systems and organs throughout the body (Robinson, 2007).
Several valve deformities can occur, and they may be genetic or develop over time due to poor lifestyle choices. The most notable include mitral valve prolapse (MVP), mitral stenosis, mitral regurgitation, aortic stenosis, and aortic regurgitation.
Mitral valve prolapse occurs when the mitral valve bulges and restricts the flow of blood through the heart. Mitral stenosis is a narrowing of the inside valve that obstructs normal blood passage. Mitral regurgitation occurs when the flow of blood is blocked and begins moving backward and to the left ventricle. Aortic stenosis causes the leaflets inside the heart to become constricted, which directly impacts the heart's ability to allow blood to flow into its chambers. Aortic regurgitation occurs when the valve does not close properly and blood begins to leak into the left ventricle (Robinson, 2007).
Each of these deformities impacts cardiac functioning by making it difficult for blood to move through the body. The heart must beat faster in order to continue functioning, and when this occurs, excessive blood builds up and the condition worsens. It is at this critical point that a person can enter cardiac arrest (Robinson, 2007).
In many cases, these valve issues have a negative impact on other body systems. For instance, acute decompensation occurs when fluid leaks into the lungs and the lymphatic system has trouble clearing the bloodstream. This makes it difficult for the person to breathe and engage in everyday physical activities (Silverstein, 2006). The combination of increased cardiac workload and fluid accumulation in vital organs can severely compromise quality of life and oxygen delivery to tissues.
To treat patients with heart valve disease requires providing supplemental oxygen, using ventilators, and administering a combination of pharmaceutical products such as nitroglycerin and diuretics. These solutions are utilized to alleviate the stress on the heart and help reduce blood pressure. This approach enables patients to experience a reduction in the severity of their symptoms. These treatment interventions address both the immediate physiological consequences of valve dysfunction and the longer-term management of heart failure progression (Robinson, 2007).
"Medications and interventions for symptom management"
Always verify citation format against your institution’s current style guide requirements.